Logo image of CRAK

VANECK OIL REFINERS ETF (CRAK) Stock Overview

NYSEARCA:CRAK - US92189F5851 - ETF

35.3949 USD
+0.19 (+0.54%)
Last: 8/27/2025, 8:04:03 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CRAK. CRAK was compared to 80 industry peers in the Automobile Components industry. Both the profitability and the financial health of CRAK get a neutral evaluation. Nothing too spectacular is happening here. CRAK has a correct valuation and a medium growth rate. Finally CRAK also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CRAK was profitable.
CRAK had a positive operating cash flow in the past year.
In the past 5 years CRAK has always been profitable.
CRAK had a positive operating cash flow in each of the past 5 years.
CRAK Yearly Net Income VS EBIT VS OCF VS FCFCRAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

1.2 Ratios

CRAK's Return On Assets of 4.39% is fine compared to the rest of the industry. CRAK outperforms 67.50% of its industry peers.
CRAK's Return On Equity of 8.81% is fine compared to the rest of the industry. CRAK outperforms 65.00% of its industry peers.
CRAK's Return On Invested Capital of 8.17% is fine compared to the rest of the industry. CRAK outperforms 63.75% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRAK is in line with the industry average of 8.49%.
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROIC 8.17%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
CRAK Yearly ROA, ROE, ROICCRAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of CRAK (5.84%) is better than 70.00% of its industry peers.
In the last couple of years the Profit Margin of CRAK has remained more or less at the same level.
The Operating Margin of CRAK (10.65%) is better than 71.25% of its industry peers.
CRAK's Operating Margin has been stable in the last couple of years.
CRAK has a better Gross Margin (27.60%) than 63.75% of its industry peers.
CRAK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
CRAK Yearly Profit, Operating, Gross MarginsCRAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRAK is still creating some value.
Compared to 1 year ago, CRAK has less shares outstanding
CRAK has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CRAK is higher compared to a year ago.
CRAK Yearly Shares OutstandingCRAK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
CRAK Yearly Total Debt VS Total AssetsCRAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

An Altman-Z score of 2.59 indicates that CRAK is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.59, CRAK is in line with its industry, outperforming 53.75% of the companies in the same industry.
CRAK has a debt to FCF ratio of 6.05. This is a slightly negative value and a sign of low solvency as CRAK would need 6.05 years to pay back of all of its debts.
CRAK has a Debt to FCF ratio (6.05) which is in line with its industry peers.
CRAK has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.32, CRAK is in line with its industry, outperforming 58.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Altman-Z 2.59
ROIC/WACC1.2
WACC6.81%
CRAK Yearly LT Debt VS Equity VS FCFCRAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.80 indicates that CRAK should not have too much problems paying its short term obligations.
With a Current ratio value of 1.80, CRAK perfoms like the industry average, outperforming 47.50% of the companies in the same industry.
A Quick Ratio of 1.12 indicates that CRAK should not have too much problems paying its short term obligations.
CRAK has a Quick ratio of 1.12. This is comparable to the rest of the industry: CRAK outperforms 47.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.12
CRAK Yearly Current Assets VS Current LiabilitesCRAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

CRAK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.28%.
CRAK shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.64% yearly.
The Revenue has decreased by -3.62% in the past year.
CRAK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.41% yearly.
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%

3.2 Future

The Earnings Per Share is expected to grow by 16.31% on average over the next years. This is quite good.
CRAK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.54% yearly.
EPS Next Y22.75%
EPS Next 2Y19.47%
EPS Next 3Y16.31%
EPS Next 5YN/A
Revenue Next Year-1.64%
Revenue Next 2Y0.47%
Revenue Next 3Y1.52%
Revenue Next 5Y2.54%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CRAK Yearly Revenue VS EstimatesCRAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
CRAK Yearly EPS VS EstimatesCRAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.88, the valuation of CRAK can be described as correct.
Based on the Price/Earnings ratio, CRAK is valued a bit cheaper than the industry average as 65.00% of the companies are valued more expensively.
CRAK's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.14.
The Price/Forward Earnings ratio is 8.12, which indicates a very decent valuation of CRAK.
Based on the Price/Forward Earnings ratio, CRAK is valued a bit cheaper than 73.75% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.80. CRAK is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.88
Fwd PE 8.12
CRAK Price Earnings VS Forward Price EarningsCRAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRAK indicates a somewhat cheap valuation: CRAK is cheaper than 70.00% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as CRAK.
Industry RankSector Rank
P/FCF 17.28
EV/EBITDA 5.15
CRAK Per share dataCRAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRAK has a very decent profitability rating, which may justify a higher PE ratio.
CRAK's earnings are expected to grow with 16.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.61
PEG (5Y)8.45
EPS Next 2Y19.47%
EPS Next 3Y16.31%

7

5. Dividend

5.1 Amount

CRAK has a Yearly Dividend Yield of 4.24%, which is a nice return.
Compared to an average industry Dividend Yield of 3.82, CRAK pays a bit more dividend than its industry peers.
CRAK's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 4.24%

5.2 History

On average, the dividend of CRAK grows each year by 7.84%, which is quite nice.
CRAK has been paying a dividend for at least 10 years, so it has a reliable track record.
CRAK has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)7.84%
Div Incr Years3
Div Non Decr Years3
CRAK Yearly Dividends per shareCRAK Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5

5.3 Sustainability

CRAK pays out 62.40% of its income as dividend. This is not a sustainable payout ratio.
CRAK's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP62.4%
EPS Next 2Y19.47%
EPS Next 3Y16.31%
CRAK Yearly Income VS Free CF VS DividendCRAK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
CRAK Dividend Payout.CRAK Dividend Payout, showing the Payout Ratio.CRAK Dividend Payout.PayoutRetained Earnings

VANECK OIL REFINERS ETF

NYSEARCA:CRAK (8/27/2025, 8:04:03 PM)

35.3949

+0.19 (+0.54%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)02-22 2026-02-22/amc
Inst Owners39.91%
Inst Owner Change-7.16%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap24.98B
Analysts80
Price Target39.67 (12.08%)
Short Float %0%
Short Ratio2.51
Dividend
Industry RankSector Rank
Dividend Yield 4.24%
Yearly Dividend1.57
Dividend Growth(5Y)7.84%
DP62.4%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.15%
PT rev (3m)21.82%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-9.31%
EPS NY rev (3m)-9.31%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.45%
Revenue NY rev (3m)-2.45%
Valuation
Industry RankSector Rank
PE 13.88
Fwd PE 8.12
P/S 0.8
P/FCF 17.28
P/OCF 6.33
P/B 1.21
P/tB 1.64
EV/EBITDA 5.15
EPS(TTM)2.55
EY7.2%
EPS(NY)4.36
Fwd EY12.31%
FCF(TTM)2.05
FCFY5.79%
OCF(TTM)5.59
OCFY15.79%
SpS44.16
BVpS29.27
TBVpS21.55
PEG (NY)0.61
PEG (5Y)8.45
Profitability
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROCE 10.41%
ROIC 8.17%
ROICexc 9.37%
ROICexgc 11.66%
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
FCFM 4.64%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
ROICexc(3y)10.37%
ROICexc(5y)9.81%
ROICexgc(3y)12.78%
ROICexgc(5y)12.13%
ROCE(3y)11.87%
ROCE(5y)10.97%
ROICexcg growth 3Y-1.65%
ROICexcg growth 5Y0.27%
ROICexc growth 3Y-2.16%
ROICexc growth 5Y0.21%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Debt/EBITDA 1.17
Cap/Depr 107.96%
Cap/Sales 8.01%
Interest Coverage 9.96
Cash Conversion 70%
Profit Quality 79.44%
Current Ratio 1.8
Quick Ratio 1.12
Altman-Z 2.59
F-Score5
WACC6.81%
ROIC/WACC1.2
Cap/Depr(3y)113.8%
Cap/Depr(5y)101.88%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
EPS Next Y22.75%
EPS Next 2Y19.47%
EPS Next 3Y16.31%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%
Revenue Next Year-1.64%
Revenue Next 2Y0.47%
Revenue Next 3Y1.52%
Revenue Next 5Y2.54%
EBIT growth 1Y-17.5%
EBIT growth 3Y1.98%
EBIT growth 5Y1.14%
EBIT Next Year66.93%
EBIT Next 3Y23.28%
EBIT Next 5Y17.49%
FCF growth 1Y-20.46%
FCF growth 3Y21.5%
FCF growth 5Y7.22%
OCF growth 1Y-10.1%
OCF growth 3Y14.27%
OCF growth 5Y5.48%